Member Info for jdt1990

Published 8 February 2021
Last updated 5 March 2021 - hide all updates
5 March 2021
Update on sample types required for validation of lateral flow devices.

8 February 2021
First published.

I had posted a snip from the original doc a few weeks back. Looks like the accepted sample methods has gone from 4 to 3, oropharyngeal has gone

These were the original ones:
anterior nares
mid-turbinate
oropharyngeal
saliva

To be honest I don't really care if they were annoyed by the email. They treat shareholders like mugs, taking chunky salaries (having very little direct equity themselves) whilst happily diluting shareholders to keep the lights on. Deadline after deadline missed but brushed off as if that's absolutely fine because of "Covid delays". Christ - plenty of other businesses have figured out how to operate in the "new norm" after a year!

I was just sick of the disregard for people invested here having been through it all before with KIBO. At least we now know where we stand to some extent. Fundamentals are great here which is what makes it more frustrating. Definitely a bottom drawer share now.

With POW having a stake in Haneti, hopefully we see some good drill results and they can push some movement on that front.

Agreed cunningfox LC is just a leech on any business he gets his hands on. As you say, pi*s enough people off in one business, spin off some assets into a new company, get existing investors to chase the “good” assets and rope in some new mugs.
Do all this while delivering nothing, taking a hefty salary and having zero skin in the game.
The man is an utter crook and expect nothing better from him.
However, I just thought it was worth a try and with KAT there are some slightly more “reputable” people involved the wider business which is why I am surprised he can play this game here.
Nothing to lose from my side -KIBO holding is basically worthless and breakeven here.

I have also posted it in reply to their latest tweet which might get it out there.
https://twitter.com/KatoroGoldplc/status/1366664595415453696

If anyone is on twitter and wants to retweet, it might make them pay attention. No hiding out in the public domain.

lebugue-addick - There is the VALMIN code which covers Fair Valuation of assets, which is encouraging to know that there is "guidance" on how this should be done fairly.

Section 8 (P26) onwards covers valuation processes.

https://www.aig.org.au/wp-content/uploads/2020/08/VALMIN_Code_2015_final.pdf

Doubt I will get a response but have sent this to LC and StBrides. I'm also sick of being treated like a mug, as a holder in both KAT and KIBO this man really grates on me.

Dear all,

Among numerous Katoro Gold shareholders, there is a growing frustration relating to the what seems to be endless process of closing the Blyvoor project funding.

Project financing was originally due in April 2020. Whilst Covid related delays are of course a factor, this deadline is now almost a year overdue. Even during the pandemic, timelines set by the company were repeatedly missed, something which is concerning. Mr Coetzee himself even stated in an interview "all is going well and on track with relation to Blyvoor" for the funding deadline to be pushed again only days later. How is this acceptable from a shareholder perspective?

The latest update shareholders received was in the Financing, Business Update and TVR RNS of 22nd Dec. I quote the below:

"The final draft versions of the SAMRAC CPR and SAMVAL valuation report referred to above, was received on 18 December 2020 and are now under review before the final version of said reports will be delivered."

We are now nearly 11 weeks on from those key reports being received, yet shareholders still await an update on progress. What is taking Katoro so long to get a deal over the line when there are so many "interested" parties? May I remind you, that as the project funding delays continue, there is no revenue to fund the fixed costs of the business. Katoro have already diluted shareholders twice via fund raises in this period whilst also issuing themselves (the board) share options.

I believe it is only fair that shareholders are given an update on progress and clear explanations as to the reasons for such lengthy delays. To which Covid cannot be the response. Which leads to my second point. Investor communication via Twitter, posting the same presentation which is now almost 9 months old is insufficient.

Regards

https://twitter.com/CKScienceJobs/status/1366361348435824640

Very true GGP. Well Only a week to find out what else they have found at HAV....

And that is assuming absolutely NOTHING else in the portfolio of licenses hits!

This is from the June 2020 presentation:
https://katorogold.com/wp-content/uploads/2020/07/Katoro-Gold-Presentation-July-2020_Final.pdf

"•Net Present Value ('NPV5') of US$131million.
•A 25% Internal Rate of Return (and a Return on Investment of 260%.
•Significant upside – Financials calculated at USD 1500/Oz.
•All-in Sustaining Cost ('AISC') of US$727 per ounce of gold (25 years).
•Total estimated free cash flow of US$267.4m across the life of the Project."

If they had parties interested at $1500 - it's hardly going to have become unattractive at $1750.

Although their future forecasts are a bit off:

•Current : $1760
•2020 : $2153
•2021 : $2279
•2022 : $2368
•2023 : $2228

If they were as busy delivering something tangible for shareholders as they are tweeting the same presentation that is nearly a year old we would all be a lot happier!
https://twitter.com/KatoroGoldplc/status/1366664595415453696

Absolutely sunnyca. The 6 month delay in the permit put a bit of a spanner in the works in terms of having to delay the first interest payment and just missing out on likely being able to pay the second time round from gold revenues.
"Expensive" short term yes, but the other option was to raise in the market, which in the current climate could well have been at a hefty discount diluting shareholders to the same extent or further. This was the quicker and safer option to keep the momentum up to first gold pour. As dj also said, after a couple of gold pours this will pale into insignificance as the company is self funded from the gold extraction.
Also, don't forget, the BOD hold a huge amount of shares here so they are aligned with us PI's.

Well that clears up the placing discussions, as expected, AIMS warrants will cover working capital until first gold pour and loan interest payment now due in June. Good news.....can get cracking on extracting the gold now and generating revenue.

Strangy really - facepalm moment that one!
Here’s some weekend homework.
“ AbC-19TM rapid antibody test”
Now have a read of the last RNS, be a good start to some clues.

Yeah he’s Mr LFT - trying to get the FDA to see sense.
His Twitter is worth a follow, he posts some good stuff.
As for Mr PCR here in the UK, wouldn’t know what he posts, blocked me for questioning the use of PCR in opening up the economy as it will isolate post infectious people.

https://twitter.com/michaelmina_lab/status/1365358122181795843

THREAD: NEW INFORMATION!
A first of its kind national survey out today from
@CCDD_HSPH
@TheCOVIDCollab
and
@HartSurveys
on at-home rapid testing
What did we learn?
86% of Americans are willing/eager to use at-home rapid tests – BUT awareness of rapid antigen tests is low

Bodes well for the US market if the FDA pull their finger out and start approving LFT's. Hopefully AVCT in the queue.

Different story in the UK sadly, plenty of people heard of them but wouldn't use them thanks to damage done by Innova and numpties like Deeks bashing them all day. Govt have some work to do here in the UK on that front!

Nothing of any note on BBG Hurst

Apologies Jerry - absolutely. Exactly what I meant and a very important clarification, in my example that is a drop of 50% AUM based on redemptions specifically. Thanks for that

Christ this is hard work. I'll try one more time they you're on your own.
The GDXJ buy/sell shares in 2 scenarios:
1. At the quarterly rebalance. The weighted market cap based calculation gives them a % allocation to each constituent stock. At that point they buy/sell to reach that target allocation %. This happens QUARTERLY.
2. In between the quarterly rebalances, should investors subscribe or redeem, the holdings have to be adjusted proportionally across all constituent stocks to either liquidate cash or invest the subscriptions, as GDXJ full invests its cash.
e.g. if GDXJ went from $5Bn AUM to $2.5Bn AUM, they would sell 50% of all holdings (i.e. proportionately to fund the outflows).
At no point does the GDXJ make an active, proprietary decision to buy/sell any of its holdings.